Detail Information of Xenobiotics
| General Information of Xenobiotics (ID: XEO02234) | ||||||
|---|---|---|---|---|---|---|
| Xenobiotics Name |
Anthraflavic acid
|
|||||
| Xenobiotics Type |
Pharmaceutical Agent(s)
|
|||||
| Classification |
Investigative Agent
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=6776"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| PubChem CID | ||||||
| DME(s) Modulated by This Xenobiotics | ||||||
| DME(s) Inhibited by This Xenobiotics | ||||||
| Unclear metabolic mechanism (DME-unclear) | DME Info | Streptococcus mutans | [1] | |||
| Glutamate racemase (MurI) | DME Info | Streptococcus mutans | [1] | |||
| References | ||||||
| 1 | In vitro inhibition of Streptococcus mutans biofilm formation on hydroxyapatite by subinhibitory concentrations of anthraquinones. Antimicrob Agents Chemother. 2007 Apr;51(4):1541-4. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.